Enhanced phagocytosis of encapsulated Escherichia coli strains after exposure to sub-MICs of antibiotics is correlated to changes of the bacterial cell surface

The influence of five antibiotics (netilmicin, ceftriaxone, cefepime, fleroxacin, and ciprofloxacin) on capsular polysaccharide distribution and on opsonophagocytosis by human polymorphonuclear leukocytes of unencapsulated and encapsulated Escherichia coli strains was studied. Unencapsulated E. coli strains were readily opsonized in serum and easily ingested by polymorphonuclear leukocytes, and antibiotics did not further enhance the phagocytosis rates. In contrast, encapsulated bacteria were poorly opsonized in human serum, and phagocytosis was enhanced after overnight exposure to 0.5x the MICs of the antibiotics, with the exception of cefepime. Incubation of unencapsulated as well as encapsulated bacteria in complement-inactivated serum markedly reduced the bacterial uptake by polymorphonuclear leukocytes regardless of the presence of antibiotics. Slide agglutination assays, performed either with a monoclonal antibody for capsular polysaccharide or with an antiserum raised against the stable unencapsulated mutant E. coli O7:K-, showed reduction but not lack of the capsular polysaccharide of encapsulated E. coli O7:K1, and better exposure of subcapsular epitopes, after incubation with 0.5x the MICs of antibiotics. Flow cytometric analysis of encapsulated E. coli exposed to netilmicin, ciprofloxacin, and fleroxacin revealed that the reduction in capsular material was homogeneous among the bacterial population. Treatment with cefepime and ceftriaxone induced two populations of bacteria that differed in the amount of K antigen present. These results indicate that sub-MICs of netilmicin, ceftriaxone, fleroxacin, and ciprofloxacin influenced complement-mediated opsonization, probably due to changes in the capsular polysaccharide structure.

[1]  G. Raponi,et al.  The influence of subminimal inhibitory concentrations of netilmicin and ceftriaxone on the interaction of Escherichia coli with host defences. , 1989, The Journal of antimicrobial chemotherapy.

[2]  C. Gemmell Changes in expression of bacterial surface antigens induced by antibiotics and their influence on host defenses. , 1987, Pathologie-biologie.

[3]  A P Phillips,et al.  Direct and indirect immunofluorescence analysis of bacterial populations by flow cytometry. , 1987, Journal of immunological methods.

[4]  P. Williams Sub-MICs of cefuroxime and ciprofloxacin influence interaction of complement and immunoglobulins with Klebsiella pneumoniae , 1987, Antimicrobial Agents and Chemotherapy.

[5]  S. Nade,et al.  Pathogenesis and treatment of acute hematogenous osteomyelitis: evaluation of current views with reference to an animal model. , 1986, Reviews of infectious diseases.

[6]  M. Rozenberg-Arska,et al.  Bactericidal, bacteriolytic and opsonic activity of human serum against Escherichia coli. , 1986, Journal of medical microbiology.

[7]  A. Cross,et al.  Role of lipopolysaccharide and capsule in the serum resistance of bacteremic strains of Escherichia coli. , 1986, The Journal of infectious diseases.

[8]  M. Rozenberg-Arska,et al.  Electron microscopic study of phagocytosis of Escherichia coli by human polymorphonuclear leukocytes , 1985, Infection and immunity.

[9]  M. R. Brown,et al.  Protein antigens of encapsulated Klebsiella pneumoniae surface exposed after growth in the presence of subinhibitory concentrations of cephalosporins , 1985, Antimicrobial Agents and Chemotherapy.

[10]  M. R. Brown,et al.  Effect of subinhibitory concentrations of cephalosporins on surface properties and siderophore production in iron-depleted Klebsiella pneumoniae , 1985, Antimicrobial Agents and Chemotherapy.

[11]  A. Cross,et al.  The importance of the K1 capsule in invasive infections caused by Escherichia coli. , 1984, The Journal of infectious diseases.

[12]  A. Cross,et al.  K1 antigen-associated resistance to the bactericidal activity of serum , 1980 .

[13]  H. Verbrugh,et al.  Quantitation of the Third Component of Human Complement Attached to the Surface of Opsonized Bacteria: Opsonin-Deficient Sera and Phagocytosis-Resistant Strains , 1979, Infection and immunity.

[14]  H. Verbrugh,et al.  Role of Escherichia coli K capsular antigens during complement activation, C3 fixation, and opsonization , 1979, Infection and immunity.

[15]  H. Verbrugh,et al.  Phagocytosis and killing of staphylococci by human polymorphonuclear and mononuclear leucocytes. , 1978, Journal of clinical pathology.

[16]  J. Verhoef,et al.  Kinetics of staphylococcal opsonization, attachment, ingestion and killing by human polymorphonuclear leukocytes: a quantitative assay using [3H]thymidine labeled bacteria. , 1977, Journal of immunological methods.

[17]  J. Costerton,et al.  Structure and function of the cell envelope of gram-negative bacteria , 1974, Bacteriological reviews.

[18]  P. Maloney,et al.  Production and Degradation of Serogroup B Neisseria meningitidis Polysaccharide , 1972, Infection and immunity.

[19]  C. Howard,et al.  The virulence for mice of strains of Escherichia coli related to the effects of K antigens on their resistance to phagocytosis and killing by complement. , 1971, Immunology.

[20]  C. Howard,et al.  The sensitivity to complement of strains of Escherichia coli related to their K antigens. , 1970, Immunology.

[21]  L. H. Muschel,et al.  The Sensitivity of Smooth and Rough Gram-Negative Bacteria to the Immune Bactericidal Reaction , 1970, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[22]  E. Wood Classification of Bacteria , 1949, Nature.

[23]  M. Horwitz,et al.  Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes. , 1980, The Journal of clinical investigation.

[24]  W. R. Mccabe,et al.  The relation of K-antigen to virulence of Escherichia coli. , 1975, The Journal of infectious diseases.